Table 1.

Case reports of Fournier’s gangrene in the setting of rectal cancer in Japan

No.	Author		Gender	Age	Location	Comorbidity	Operation	Outcome
1	Futamura et al. [6]	1995	M	56	Rb	None	APR	4 years and 7 months, alive
2	Fujisawa et al. [7]	1999	M	75	Rb	None	None	Death at 6 days
3	Nakao et al. [8]	1999	M	51	Rb	DM	None	Unknown
4	Saito et al. [9]	2000	M	60	Rb	None	TPE	1 year, alive
5	Noriyuki et al. [10]	2003	M	58	Ra	DM	5-FU + LV	1 year and 2 months, alive
6	Enomoto at al. [11]	2006	M	35	Rb	None	APR	3 months, alive
7	Moriwaki et al. [12]	2007	M	30	Rb-P	Unknown	APR	Death at 11 months
8	Kojima et al. [13]	2007	M	56	Rb	DM	TPE	4 months, alive
9	Morohashi et al. [14]	2008	M	60	Rb	DM	None	Death at 2 months
10	Ishibashi et al. [15]	2009	F	80	Rb	HT	APR	2 months, alive
11	Yamazaki et al. [16]	2010	M	50s	Rb	DM	APR	1 months, alive
12	Onizuka et al. [17]	2010	M	55	Rs	None	Chemo	1 year and 2 months, alive
13	Tanaka et al. [18]	2010	F	52	Rb	DM	APR	5 months, alive
14	Watabe et al. [19]	2013	M	77	Rb-P	Unknown	None	2 months, alive
15	Monma et al. [20]	2013	M	79	P	HT	CRT	1 year, alive
16	Kawagoe et al. [21]	2014	M	72	Rb	None	FOLFOX + bev	6 months, alive
17	Our case	2016	M	65	Rb	None	TPE	Death at 1 year

M male, F female, Rb lower rectum, Rs rectosigmoid colon, P proctos, APR abdominoperineal resection, TPE total pelvic exenteration, Chemo chemotherapy, CRT chemoradiation therapy, Bev bevacizumab, DM diabetes mellitus, HT hypertension